Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Lytham Partners Summer 2021 Investor Conference
 Monday, June 14, 2021
 3:30pm EDT